Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.
Neuromod Devices has raised $10.9M in total funding. The most recent round was Series B. The last funding was announced in March 2025.
Neuromod Devices's investors include European Investment Bank, Enterprise Ireland, Panakes Partners, Kreos Capital, Silicon Valley Bank.
Neuromod Devices is headquartered in Dublin, Ireland.
Neuromod Devices has developed LENIRE® (www.lenire.com) a non-invasive bimodal neuromodulation therapy for tinnitus.
Neuromod Devices is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neuromod Devices — Funding & Investors." VCBacked, March 11, 2025, https://www.vcbacked.co/company/neuromod-devices. Accessed November 15, 2026.
VCBacked. (2025). Neuromod Devices — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/neuromod-devices
{{cite web |title=Neuromod Devices — Funding & Investors |url=https://www.vcbacked.co/company/neuromod-devices |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Neuromod Devices? Request a listing update